Skip to content

IMDX IMDX EBITDA margin

EBITDA margin at other companies

CareDx logo
CareDxCDNA
-0.2%-18.7pp
Guardant Health logo
Guardant HealthGH
-37.8%-8.5pp
Natera, Inc. logo
Natera, Inc.NTRA
-11.1%+0.5pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-25.5%+32.9pp
Agilent Technologies logo
Agilent TechnologiesA
25.3%-0.2pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-143.7%-918pp

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Calculated from IMDX’s reported figures.

Based on trailing twelve months.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's EBITDA margin?
IMDX (IMDX) reported EBITDA margin of -2,380.8% in Q1 2026.
How has IMDX's EBITDA margin changed year-over-year?
IMDX's EBITDA margin decreased by 60.7% year-over-year, from -1,481.3% to -2,380.8%.
What is the long-term trend for IMDX's EBITDA margin?
Over 5 years (2020 to 2025), IMDX's EBITDA margin has grown at a -12.9% compound annual growth rate (CAGR), from -2,408.9% to -1,206.8%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.